USA expects to begin Covid vaccinations by 11 December

On November 11, Russian Federation had said that its vaccine Sputnik V is 92 per cent effective at protecting people from COVID-19 according to the first interim analysis.

"Our plan is to be able to ship vaccines to the immunization sites within 24 hours of approval" by the US Food and Drug Administration, Moncef Slaoui told CNN.

A woman holds a small bottle labeled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020.

The price per dose of the Russian coronavirus vaccine Sputnik V will be much lower than that of the vaccines of United States drug giants Pfizer and Moderna, said the Russian vaccine's official Twitter account on Sunday.

Meanwhile, Russian drugmaker Sputnik V claimed that its vaccine would be cheaper than those of Moderna and Pfizer. "Moderna had earlier stated that its vaccine might be priced between $25 and $37 per dose".

The statement comes shortly after USA pharmaceutical company Moderna announced that it would charge countries that want to buy its candidate vaccine against COVID-19 between $25 and $37 per dose.

A spokesperson for the Russian Direct Investment Fund (RDIF), which is investing in the production and promotion of the vaccine overseas, said that the price of Sputnik V would be unveiled next week. "The price of Sputnik V will be much lower", Sputnik V wrote on Twitter on November 22.

In a major development, it has emerged that a COVID-19 vaccine undergoing the third phase of a clinical trial in Pakistan has shown promising results, ARY NEWS reported on Friday. "We continue to move at the speed of science to compile all the data collected thus far and share with regulators around the world", Pfizer Chief Executive Albert Bourla said.

Latest News